Zacks
What to Expect From These Drug/Biotech Players This Earnings Season?
📊
AI Sentiment
Positive
7/10
Novartis AG News
Latest updates and market news for NVS
20 news
Feb 11 - Feb 17, 2026
Page 1
Motley Fool
Promethos Capital Liquidates $4 Million Sprouts Farmers Market Position: Should Investors Sell, Too?
📉
AI Sentiment
Negative
3/10
Pharmaceutical Technology
Theranostics earmarked as “the future” of radiopharmaceuticals
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Should Vanrafia Kidney Data and Dividend Move Reshape the Novartis (SWX:NOVN) Autoimmune Investment Case?
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Is It Too Late To Consider Novartis (SWX:NOVN) After Strong Multi‑Year Share Gains?
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Sector Update: Health Care Stocks Higher Friday Afternoon
📈
AI Sentiment
Highly Positive
8/10
Zacks
NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Sector Update: Health Care Stocks Edge Higher Premarket Friday
📊
AI Sentiment
Positive
6/10
MT Newswires
Novartis Says Vanrafia Late-Stage Data Support Slowing of Kidney Function Decline in IgA Nephropathy Patients
➖
AI Sentiment
Neutral
5/10
Simply Wall St.
Novartis Actinium 225 Deal Supports Radioligand Focus And Valuation Case
📈
AI Sentiment
Highly Positive
8/10
The Wall Street Journal
Novartis Says Vanrafia Drug Slows Kidney Function Decline
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
Sanofi Tumbles After Board Shockingly Ousts CEO Paul Hudson
📉
AI Sentiment
Negative
3/10
MarketBeat
Avalo Therapeutics Eyes Q2 2026 Phase IIb LOTUS Readout for AVTX-009 in Hidradenitis Suppurativa
📊
AI Sentiment
Positive
7/10
PR Newswire
Niowave and Novartis Enter Global Actinium-225 Supply Agreement to Advance Next-Generation Cancer Therapies
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Novartis Expands AI Research Footprint As Kisqali Access Progresses In Canada
📈
AI Sentiment
Highly Positive
8/10
Share this news page